Fougera Pharms Drug Patent Portfolio

Fougera Pharms owns 2 orange book drugs protected by 7 US patents Given below is the list of Fougera Pharms's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7300669 Fluticasone lotion having improved vasoconstrictor activity 20 Oct, 2019 Expired
US5792753 Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs 11 Aug, 2015 Expired
US5914322 Treatment of disease and conditions 11 Aug, 2015 Expired
US5985850 Compositions comprising hyaluronic acid and drugs 11 Aug, 2015 Expired
US5639738 Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs 17 Jun, 2014 Expired
US5852002 Treatment of conditions and disease 17 Jun, 2014 Expired
US5929048 Treatment of conditions and disease 17 Jun, 2014 Expired


Given below is the list of recent legal activities going on the following drug patents of Fougera Pharms.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 12th Year, Large Entity 16 May, 2019 US7300669
Email Notification 07 Oct, 2011 US7300669
Grant Request for Retroactive License 21 Sep, 2011 US7300669
Email Notification 31 May, 2011 US7300669
Change in Power of Attorney (May Include Associate POA) 31 May, 2011 US7300669
Correspondence Address Change 26 May, 2011 US7300669
Request for Retroactive License 23 Dec, 2010 US7300669
Recordation of Patent Grant Mailed 27 Nov, 2007 US7300669
Patent Issue Date Used in PTA Calculation 27 Nov, 2007 US7300669
Issue Notification Mailed 07 Nov, 2007 US7300669
Dispatch to FDC 29 Oct, 2007 US7300669
Application Is Considered Ready for Issue 09 Oct, 2007 US7300669
Issue Fee Payment Received 04 Oct, 2007 US7300669
Reverse Issue Fee 04 Oct, 2007 US7300669
Issue Fee Payment Verified 04 Oct, 2007 US7300669


Fougera Pharms's Family Patents


Family Patents



Fougera Pharms Drug List

Given below is the complete list of Fougera Pharms's drugs and the patents protecting them.


1. Cutivate

Cutivate is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7300669 Fluticasone lotion having improved vasoconstrictor activity 20 Oct, 2019
(4 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Cutivate's drug page


2. Solaraze

Solaraze is protected by 6 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5792753 Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs 11 Aug, 2015
(9 years ago)
Expired
US5914322 Treatment of disease and conditions 11 Aug, 2015
(9 years ago)
Expired
US5985850 Compositions comprising hyaluronic acid and drugs 11 Aug, 2015
(9 years ago)
Expired
US5639738 Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs 17 Jun, 2014
(10 years ago)
Expired
US5852002 Treatment of conditions and disease 17 Jun, 2014
(10 years ago)
Expired
US5929048 Treatment of conditions and disease 17 Jun, 2014
(10 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Solaraze's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List